757
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Pelvic inflammatory disease among users and non-users of an intrauterine device

ORCID Icon, , , , &

References

  • Anon. 1982. The bacteriology of acute pelvic inflammatory disease. Lancet 1:431–432.
  • Beerthuizen RJ. 1996. Pelvic inflammatory disease in intrauterine device users. The European Journal of Contraception & Reproductive Health Care 1:237–243.
  • Bohm MK, Newman L, Satterwhite CL, Tao G, Weinstock HS. 2010. Pelvic inflammatory disease among privately insured women, United States, 2001–2005. Sexually Transmitted Diseases 37:131–136.
  • [CDC], C.F.D.C.A.P. 1995. Ectopic pregnancy – United States, 1990–1992. Morbidity and Mortality Weekly Report 44:46–48.
  • Chow AW, Malkasian KL, Marshall JR, Guze LB. 1975. The bacteriology of acute pelvic inflammatory disease. American Journal of Obstetrics and Gynecology 122:876–879.
  • Curtis KM, Jatlaoui TC, Tepper NK, Zapata LB, Horton LG, Jamieson DJ, et al. 2016. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports 65:1–66.
  • Eschenbach DA, Buchanan TM, Pollock HM, Forsyth PS, Alexander ER, Lin JS, et al. 1975. Polymicrobial etiology of acute pelvic inflammatory disease. The New England Journal of Medicine 293:166–171.
  • Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. 1992. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 339:785–788.
  • Fouks Y, Many A, Amit S, Levin I, Meiri A, Shinar S. 2019. Is there a benefit to culturing intra-uterine devices in pelvic inflammatory disease? Gynecologic and Obstetric Investigation 84:20–26.
  • Grimes DA. 2000. Intrauterine device and upper-genital-tract infection. Lancet 356:1013–1019.
  • Grimes DA, Schulz KF. 2001. Antibiotic prophylaxis for intrauterine contraceptive device insertion. Cochrane Database of Systematic Reviews 3:CD001327.
  • Hager WD, Eschenbach DA, Spence MR, Sweet RL. 1983. Criteria for diagnosis and grading of salpingitis. Obstetrics and Gynecology 61:113–114.
  • Havens JM, Olufajo OA, Cooper ZR, Haider AH, Shah AA, Salim A. 2016. Defining rates and risk factors for readmissions following emergency general surgery. JAMA Surgery 151:330–336.
  • Hubacher D, Grimes DA, Gemzell-Danielsson K. 2013. Pitfalls of research linking the intrauterine device to pelvic inflammatory disease. Obstetrics and Gynecology 121:1091–1098.
  • Hubacher D. 2014. Intrauterine devices and infection: review of the literature. Indian Journal of Medical Research 140:S53–S57.
  • Jatlaoui TC, Riley HEM, Curtis KM. 2017. The safety of intrauterine devices among young women: a systematic review. Contraception 95:17–39.
  • Kaneshiro B, Aeby T. 2010. Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device. International Journal of Women's Health 2:211–220.
  • Kessel E. 1989. Pelvic inflammatory disease with intrauterine device use: a reassessment. Fertility and Sterility 51:1–11.
  • Liabsuetrakul T, Peeyananjarassri K. 2018. Mechanical dilatation of the cervix during elective caeserean section before the onset of labour for reducing postoperative morbidity. The Cochrane Database of Systematic Reviews 8:CD008019.
  • Lobo RAM, Gershenson DM, Lentz GM. 2017. Comprehensive gynecology. 7th ed. Amsterdam (NL):Elsevier.
  • Mishell DR, Bell JH, Good RG, Moyer DL. 1966. The intrauterine device: a bacteriologic study of the endometrial cavity. American Journal of Obstetrics and Gynecology 96:119–126.
  • Mohllajee AP, Curtis KM, Peterson HB. 2006. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review. Contraception 73:145–153.
  • Myriam Safrai AR, Shushan A, Gilad R, Benshushan A, Levin G. 2019. Risk factors for recurrent pelvic inflammatory disease. European Journal of Obstetrics and Gynecology and Reproductive Biology 244:40–44.
  • Nelson AL. 2007. Contraindications to IUD and IUS use. Contraception 75:S76–S81.
  • Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL, et al. 2002. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. American Journal of Obstetrics and Gynecology 186:929–937.
  • Ness RB, Trautmann G, Richter HE, Randall H, Peipert JF, Nelson DB, et al. 2005. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstetrics and Gynecology 106:573–580.
  • Pál Z, Urbán E, Dósa E, Pál A, Nagy E. 2005. Biofilm formation on intrauterine devices in relation to duration of use. Journal of Medical Microbiology 54:1199–1203.
  • Quentin R, Verdon R. 2012. Microbiologic basis of diagnosis and treatment of pelvic inflammatory disease. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 41:850–863.
  • Svensson L, Weström L, Mårdh PA. 1984. Contraceptives and acute salpingitis. JAMA 251:2553–2555.
  • Tepper NK, Steenland MW, Gaffield ME, Marchbanks PA, Curtis KM. 2013. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review. Contraception 87:655–660.
  • Tsanadis G, Kalantaridou SN, Kaponis A, Paraskevaidis E, Zikopoulos K, Gesouli E, et al. 2002. Bacteriological cultures of removed intrauterine devices and pelvic inflammatory disease. Contraception 65:339–342.
  • Viberga I, Odlind V, Lazdane G, Kroica J, Berglund L, Olofsson S. 2005. Microbiology profile in women with pelvic inflammatory disease in relation to IUD use. Infectious Diseases in Obstetrics and Gynecology 13:183–190.
  • Workowski KA, Bolan GA, Prevention CFDCA. 2015. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recommendations and Reports 64:1–137.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.